Tirzepatide has shown superior glycemic control compared to other GLP-1s, likely due to its dual action on GIP and GLP-1 receptors
Midi offers a compounded version through reputable, strictly-regulated pharmacies
High-yield reporting fields for suspected semaglutide-related vaginal symptoms include: dose and escalation dates, concomitant SGLT2 inhibitor use, antibiotic/antifungal use, menopausal status/HRT, diabetes control markers, symptom description with onset/offset, objective test results (pH, microscopy/NAAT), and dechallenge/rechallenge outcomes if they occur
The search covered databases including PubMed, MEDLINE, Embase, Web of Science, and Reprotox, from their inception through January 2026, along with references from qualifying studies